首页 > 最新文献

Contraception: X最新文献

英文 中文
From policy to practice: Experiences from the ECHO trial following revisions of the WHO medical eligibility criteria for contraceptive use (MEC) guidance on DMPA-IM 从政策到实践:世卫组织避孕药具使用医疗资格标准(MEC)DMPA-IM 指南修订后的 ECHO 试验经验
Q2 Medicine Pub Date : 2024-01-01 DOI: 10.1016/j.conx.2024.100111
Petrus Steyn , Mags Beksinska , Melanie Pleaner , Hui-Zhen Tam , Jenni Smit , Kathy Baisley , Douglas Taylor , Mandisa Singata-Madliki , G. Justus Hofmeyr , Thesla Palanee-Phillips , James N. Kiarie

Objectives

In 2017, the World Health Organization (WHO) medical eligibility criteria (MEC) for contraception category for intramuscular depot medroxyprogesterone acetate (DMPA-IM) was changed from MEC category 1 to 2 for women at high risk of HIV acquisition. We assessed the impact of communicating this category change among women in the Evidence for Contraceptive options and HIV Outcomes (ECHO) trial.

Study design

ECHO was conducted in eSwatini, Kenya, South Africa and Zambia. Women were randomized (1:1:1) to DMPA-IM, levonorgestrel (LNG) implant or copper intrauterine device (Cu IUD). We compared the hazards of DMPA-IM discontinuation and assessed sexual behavior and DMPA-IM satisfaction before and after MEC category change.

Results

In DMPA-IM users there was a decrease in the hazards of discontinuation after the MEC change (hazard ratio 0.37; 95% CI = 0.26–0.52, p < 0.001). No evidence of an effect of the MEC change was observed in sexual behaviour outcomes. There was some evidence of an increase in disatisfaction with DMPA-IM immediately after the MEC change, with the odds of women reporting a higher score (more dissatisfied) increasing by 1.38 compared with before the MEC change (95% CI = 1.11–1.72).

Conclusions

While counseling on possible theoretical risks associated with contraceptive methods in the MEC is an important medical ethical standard, in this study it did not adversely impact continuation or sexual behavior, while there was some evidence on increase in dissatisfaction. There is however a need to monitor how changes in MEC categories are implemented.

Implications

Although we found no evidence in this analysis of an effect of the MEC change on any of the sexual behavioral outcomes among women after the change in category, it is still an important medical ethical standard to counsel on possible theoretical risks associated with contraceptive methods. Given the challenges of translating research findings to guidelines and further to counseling messages, evaluation of clinical guidelines implementation is necessary to understand the effects of implementation and to monitor both intended impacts and unintended consequences.
目标2017年,世界卫生组织(WHO)针对HIV感染高风险女性的醋酸甲羟孕酮肌肉注射剂(DMPA-IM)避孕类别医疗资格标准(MEC)从MEC类别1改为2。我们评估了在 "避孕选择与艾滋病结果证据"(ECHO)试验中通报这一类别变化对妇女的影响。研究设计ECHO 在斯瓦蒂尼、肯尼亚、南非和赞比亚进行。妇女被随机(1:1:1)分配到DMPA-IM、左炔诺孕酮(LNG)植入或铜宫内节育器(Cu IUD)。我们比较了停用 DMPA-IM 的危险性,并评估了 MEC 类别变更前后的性行为和 DMPA-IM 满意度。结果 DMPA-IM 使用者在 MEC 变更后停用的危险性降低(危险比 0.37;95% CI = 0.26-0.52,p <0.001)。在性行为结果方面,没有观察到改变《多指标类集调查》有影响的证据。有证据表明,在改变 MEC 后,妇女对 DMPA-IM 的不满意度立即增加,与改变 MEC 前相比,报告得分更高(更不满意)的几率增加了 1.38(95% CI = 1.11-1.72)。启示虽然我们在本分析中没有发现任何证据表明 MEC 的改变对改变类别后妇女的性行为结果产生了影响,但就避孕方法可能存在的理论风险提供咨询仍是一项重要的医学伦理标准。鉴于将研究结果转化为指南并进一步转化为咨询信息所面临的挑战,有必要对临床指南的实施情况进行评估,以了解实施效果并监测预期影响和意外后果。
{"title":"From policy to practice: Experiences from the ECHO trial following revisions of the WHO medical eligibility criteria for contraceptive use (MEC) guidance on DMPA-IM","authors":"Petrus Steyn ,&nbsp;Mags Beksinska ,&nbsp;Melanie Pleaner ,&nbsp;Hui-Zhen Tam ,&nbsp;Jenni Smit ,&nbsp;Kathy Baisley ,&nbsp;Douglas Taylor ,&nbsp;Mandisa Singata-Madliki ,&nbsp;G. Justus Hofmeyr ,&nbsp;Thesla Palanee-Phillips ,&nbsp;James N. Kiarie","doi":"10.1016/j.conx.2024.100111","DOIUrl":"10.1016/j.conx.2024.100111","url":null,"abstract":"<div><h3>Objectives</h3><div>In 2017, the World Health Organization (WHO) medical eligibility criteria (MEC) for contraception category for intramuscular depot medroxyprogesterone acetate (DMPA-IM) was changed from MEC category 1 to 2 for women at high risk of HIV acquisition. We assessed the impact of communicating this category change among women in the Evidence for Contraceptive options and HIV Outcomes (ECHO) trial.</div></div><div><h3>Study design</h3><div>ECHO was conducted in eSwatini, Kenya, South Africa and Zambia. Women were randomized (1:1:1) to DMPA-IM, levonorgestrel (LNG) implant or copper intrauterine device (Cu IUD). We compared the hazards of DMPA-IM discontinuation and assessed sexual behavior and DMPA-IM satisfaction before and after MEC category change.</div></div><div><h3>Results</h3><div>In DMPA-IM users there was a decrease in the hazards of discontinuation after the MEC change (hazard ratio 0.37; 95% CI<!--> <!-->=<!--> <!-->0.26–0.52, <em>p</em> &lt; 0.001). No evidence of an effect of the MEC change was observed in sexual behaviour outcomes. There was some evidence of an increase in disatisfaction with DMPA-IM immediately after the MEC change, with the odds of women reporting a higher score (more dissatisfied) increasing by 1.38 compared with before the MEC change (95% CI<!--> <!-->=<!--> <!-->1.11–1.72).</div></div><div><h3>Conclusions</h3><div>While counseling on possible theoretical risks associated with contraceptive methods in the MEC is an important medical ethical standard, in this study it did not adversely impact continuation or sexual behavior, while there was some evidence on increase in dissatisfaction. There is however a need to monitor how changes in MEC categories are implemented.</div></div><div><h3>Implications</h3><div>Although we found no evidence in this analysis of an effect of the MEC change on any of the sexual behavioral outcomes among women after the change in category, it is still an important medical ethical standard to counsel on possible theoretical risks associated with contraceptive methods. Given the challenges of translating research findings to guidelines and further to counseling messages, evaluation of clinical guidelines implementation is necessary to understand the effects of implementation and to monitor both intended impacts and unintended consequences.</div></div>","PeriodicalId":10655,"journal":{"name":"Contraception: X","volume":"6 ","pages":"Article 100111"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142533158","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Outpatient medical management of later second trimester abortion (18–23.6 weeks) with procedural evacuation backup: A large case series 第二孕期晚期(18-23.6 周)人工流产的门诊医疗管理与手术排空备份:大型病例系列
Q2 Medicine Pub Date : 2024-01-01 DOI: 10.1016/j.conx.2024.100104
Sruthi Chandrasekaran , Samantha Ruggiero , Gabrielle Goodrick

Objective

Document the clinical outcomes of an outpatient medical management with procedural evacuation backup procedure for abortions between 18 weeks zero days to 23 weeks six days gestation.

Study design

We conducted a retrospective medical records review of adult patients who received mifepristone and repeated misoprostol for second trimester abortion with procedural evacuation backup at an Arizona clinic between October 2017 and November 2021. We extracted patient demographics; pregnancy and medical history; and preoperative, intraoperative, and postoperative data. We assessed abortion outcomes, including procedure timing, mode of completion (medication alone or medications and procedural evacuation), and safety.

Results

All 359 patients had a complete abortion with 63.5% of patients completing with medication alone and 36.5% with procedural evacuation backup. The median time from first dose of misoprostol to fetal expulsion was six hours, among those who completed the abortion with medications alone. Of those who received procedural evacuation as backup, the median time for procedural evacuation was 10 minutes. The vast majority of patients (99.4%) did not have any adverse events. Two safety incidents (0.6%) occurred, a broad right ligament tear and a uterine rupture.

Conclusion

Patients in one outpatient setting safely and effectively received medical management of second trimester abortion with procedural evacuation backup, and two thirds completed with medications alone.

Implications

Outpatient settings may consider medical management of abortion between 18 and 24 weeks with procedural evacuation back-up as a safe, effective, and manageable second trimester abortion option. Additional research is needed on patient experience and satisfaction.

研究设计我们对2017年10月至2021年11月期间在亚利桑那州一家诊所接受米非司酮和重复米索前列醇进行第二孕期人工流产并进行程序性排空备份的成年患者进行了回顾性病历审查。我们提取了患者的人口统计学特征、妊娠史和病史,以及术前、术中和术后数据。我们评估了流产结果,包括手术时间、完成方式(单纯药物流产或药物流产和手术排空)和安全性。结果所有359名患者都完成了流产,其中63.5%的患者单纯药物流产,36.5%的患者通过手术排空完成。在仅使用药物完成流产的患者中,从首次服用米索前列醇到胎儿排出的中位时间为 6 小时。在接受手术排空作为后备方案的患者中,手术排空的中位时间为 10 分钟。绝大多数患者(99.4%)未发生任何不良事件。结论在一个门诊环境中,患者安全有效地接受了第二孕期人工流产的医疗管理,并接受了程序性排空术作为后备,三分之二的患者仅用药物就完成了流产。还需要对患者的体验和满意度进行更多研究。
{"title":"Outpatient medical management of later second trimester abortion (18–23.6 weeks) with procedural evacuation backup: A large case series","authors":"Sruthi Chandrasekaran ,&nbsp;Samantha Ruggiero ,&nbsp;Gabrielle Goodrick","doi":"10.1016/j.conx.2024.100104","DOIUrl":"10.1016/j.conx.2024.100104","url":null,"abstract":"<div><h3>Objective</h3><p>Document the clinical outcomes of an outpatient medical management with procedural evacuation backup procedure for abortions between 18 weeks zero days to 23 weeks six days gestation.</p></div><div><h3>Study design</h3><p>We conducted a retrospective medical records review of adult patients who received mifepristone and repeated misoprostol for second trimester abortion with procedural evacuation backup at an Arizona clinic between October 2017 and November 2021. We extracted patient demographics; pregnancy and medical history; and preoperative, intraoperative, and postoperative data. We assessed abortion outcomes, including procedure timing, mode of completion (medication alone or medications and procedural evacuation), and safety.</p></div><div><h3>Results</h3><p>All 359 patients had a complete abortion with 63.5% of patients completing with medication alone and 36.5% with procedural evacuation backup. The median time from first dose of misoprostol to fetal expulsion was six hours, among those who completed the abortion with medications alone. Of those who received procedural evacuation as backup, the median time for procedural evacuation was 10 minutes. The vast majority of patients (99.4%) did not have any adverse events. Two safety incidents (0.6%) occurred, a broad right ligament tear and a uterine rupture.</p></div><div><h3>Conclusion</h3><p>Patients in one outpatient setting safely and effectively received medical management of second trimester abortion with procedural evacuation backup, and two thirds completed with medications alone.</p></div><div><h3>Implications</h3><p>Outpatient settings may consider medical management of abortion between 18 and 24 weeks with procedural evacuation back-up as a safe, effective, and manageable second trimester abortion option. Additional research is needed on patient experience and satisfaction.</p></div>","PeriodicalId":10655,"journal":{"name":"Contraception: X","volume":"6 ","pages":"Article 100104"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2590151624000017/pdfft?md5=4b9a10865d037e23471fc79f87a10c0b&pid=1-s2.0-S2590151624000017-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139965477","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
How does person-centered maternity care relate to postpartum contraceptive counseling and use? Evidence from a longitudinal study of women delivering at health facilities in Ethiopia 以人为本的产妇护理与产后避孕咨询和使用有何关系?来自埃塞俄比亚医疗机构分娩妇女纵向研究的证据
Q2 Medicine Pub Date : 2024-01-01 DOI: 10.1016/j.conx.2024.100109
Elizabeth K. Stierman , Celia Karp , Jiage Qian , Solomon Shiferaw , Assefa Seme , Mahari Yihdego , Saifuddin Ahmed , Andreea A. Creanga , Linnea A. Zimmerman

Objectives

This study examines the relationship between integrated, person-centered maternity care (PCMC), the provision of postpartum family planning (PPFP) services, and postpartum contraceptive use among women delivering at health facilities in Ethiopia.

Study design

We analyze 2019–2021 longitudinal data from a representative sample of pregnant and recently postpartum women in Ethiopia. This study examines baseline, 6-week, and 6-month survey data collected from women who delivered at a health facility.

Results

Maternity patients who reported more person-centered care were more likely to be counseled on postpartum contraceptive methods before discharge. Overall, 27.5% of women delivering in a health facility received family planning counseling before discharge, ranging from 15.2% in the lowest PCMC quintile to 36.3% in the highest PCMC quintile. The receipt of PPFP counseling was associated with increased odds of postpartum contraceptive use.

Conclusions

Findings suggest dimensions of quality care are interlinked, and person-centered care is associated with greater integration of recommended PPFP services into predischarge procedures. However, even among women who report relatively high levels of person-centered care, our results highlight that family planning is not routinely discussed prior to discharge from delivery, and very few women receive a contraceptive method or referral prior to discharge.

Implications

While most postpartum women report they wish to limit or space future pregnancies, the uptake of modern contraceptive methods in the postpartum period is low. As women increasingly opt to deliver in health facilities, further integration of family planning services into predischarge procedures within maternity care can improve contraceptive access.

Data statement

The data used in these analyses were collected as part of the PMA Ethiopia study. Data are publicly available at https://www.pmadata.org/data/request-access-datasets.

目的本研究探讨了综合的、以人为本的孕产妇护理(PCMC)、产后计划生育(PPFP)服务的提供与埃塞俄比亚医疗机构分娩妇女产后避孕药具使用之间的关系。研究设计我们分析了来自埃塞俄比亚孕妇和近期产后妇女代表性样本的 2019-2021 年纵向数据。本研究审查了从在医疗机构分娩的妇女处收集的基线、6 周和 6 个月调查数据。结果报告了更多以人为本护理的产妇更有可能在出院前接受有关产后避孕方法的咨询。总体而言,27.5% 在医疗机构分娩的产妇在出院前接受了计划生育咨询,其中 PCMC 五分位数最低的产妇接受咨询的比例为 15.2%,PCMC 五分位数最高的产妇接受咨询的比例为 36.3%。接受 PPFP 咨询与产后使用避孕药具的几率增加有关。结论研究结果表明,优质护理的各个层面是相互关联的,以人为本的护理与将推荐的 PPFP 服务更多地纳入出院前程序有关。尽管大多数产后妇女表示希望限制或间隔未来的怀孕时间,但产后现代避孕方法的使用率却很低。随着越来越多的妇女选择在医疗机构分娩,进一步将计划生育服务纳入产科护理的出院前程序,可以提高避孕率。数据可在 https://www.pmadata.org/data/request-access-datasets 网站上公开获取。
{"title":"How does person-centered maternity care relate to postpartum contraceptive counseling and use? Evidence from a longitudinal study of women delivering at health facilities in Ethiopia","authors":"Elizabeth K. Stierman ,&nbsp;Celia Karp ,&nbsp;Jiage Qian ,&nbsp;Solomon Shiferaw ,&nbsp;Assefa Seme ,&nbsp;Mahari Yihdego ,&nbsp;Saifuddin Ahmed ,&nbsp;Andreea A. Creanga ,&nbsp;Linnea A. Zimmerman","doi":"10.1016/j.conx.2024.100109","DOIUrl":"10.1016/j.conx.2024.100109","url":null,"abstract":"<div><h3>Objectives</h3><p>This study examines the relationship between integrated, person-centered maternity care (PCMC), the provision of postpartum family planning (PPFP) services, and postpartum contraceptive use among women delivering at health facilities in Ethiopia.</p></div><div><h3>Study design</h3><p>We analyze 2019–2021 longitudinal data from a representative sample of pregnant and recently postpartum women in Ethiopia. This study examines baseline, 6-week, and 6-month survey data collected from women who delivered at a health facility.</p></div><div><h3>Results</h3><p>Maternity patients who reported more person-centered care were more likely to be counseled on postpartum contraceptive methods before discharge. Overall, 27.5% of women delivering in a health facility received family planning counseling before discharge, ranging from 15.2% in the lowest PCMC quintile to 36.3% in the highest PCMC quintile. The receipt of PPFP counseling was associated with increased odds of postpartum contraceptive use.</p></div><div><h3>Conclusions</h3><p>Findings suggest dimensions of quality care are interlinked, and person-centered care is associated with greater integration of recommended PPFP services into predischarge procedures. However, even among women who report relatively high levels of person-centered care, our results highlight that family planning is not routinely discussed prior to discharge from delivery, and very few women receive a contraceptive method or referral prior to discharge.</p></div><div><h3>Implications</h3><p>While most postpartum women report they wish to limit or space future pregnancies, the uptake of modern contraceptive methods in the postpartum period is low. As women increasingly opt to deliver in health facilities, further integration of family planning services into predischarge procedures within maternity care can improve contraceptive access.</p></div><div><h3>Data statement</h3><p>The data used in these analyses were collected as part of the PMA Ethiopia study. Data are publicly available at <span><span>https://www.pmadata.org/data/request-access-datasets</span><svg><path></path></svg></span>.</p></div>","PeriodicalId":10655,"journal":{"name":"Contraception: X","volume":"6 ","pages":"Article 100109"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2590151624000066/pdfft?md5=c2ae99f30af75ef06f555c6c381bb03a&pid=1-s2.0-S2590151624000066-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142040714","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Maximizing the effectiveness of 1.5 mg levonorgestrel for emergency contraception: The case for precoital use 将 1.5 毫克左炔诺孕酮用于紧急避孕的效果最大化:婚前使用的案例
Q2 Medicine Pub Date : 2024-01-01 DOI: 10.1016/j.conx.2024.100107
Douglas J. Taylor , Nathalie Kapp , Markus J. Steiner

Objectives

U.S. and World Health Organization Selected Practice Recommendations for Contraceptive Use state people may have an advanced supply of emergency contraception (EC) to minimize treatment delays. We sought to characterize the potential improvement in effectiveness of 1.5 mg levonorgestrel (LNG-EC) if it were taken up to a few hours before unprotected sex.

Study design

We expanded on an existing mathematical model for the maximum attainable effectiveness of LNG-EC, assuming it exclusively works to disrupt ovulation, and compared results with point estimates from nine studies when it was taken up to 72 hours after sex. We then modelled how effectiveness might have improved if subjects had taken LNG-EC up to 3 hours before sex.

Results

Taking LNG-EC immediately after sex could potentially reduce the risk of unintended pregnancy by 91%. However, population-average maximum attainable effectiveness levels ranged from just 49% to 67% when accounting for the distributions of postcoital treatment delays in the example studies. If half the subjects had taken it 3 hours before sex, then maximum effectiveness levels would have ranged from 70% to 81%.

Conclusions

At the individual level, taking LNG-EC a few hours before sex is a logical extension of Selected Practice Recommendations regarding an advanced supply of EC and, based on our modeling, should be advocated for people who can reasonably anticipate an unprotected sex act. In the absence of more clinical data, however, people should not routinely rely on precoital use of LNG-EC to prevent pregnancy unless modern, effective contraceptives are inaccessible to them.

Implications

Based on mathematical modeling, individuals who anticipate needing to take LNG-EC for an impending unprotected act of sex could further reduce their chance of an undesired pregnancy by taking it a few hours in advance.

研究目的美国和世界卫生组织的《避孕药具使用实践建议选编》指出,人们可以提前服用紧急避孕药物 (EC),以尽量减少治疗延迟。研究设计我们扩展了现有的 LNG-EC 最大可达到效果的数学模型,假设它只起干扰排卵的作用,并将结果与九项研究中在性生活后 72 小时内服用的点估计值进行了比较。然后,我们模拟了如果受试者在性爱前 3 小时内服用 LNG-EC 可能会提高的有效性。然而,如果考虑到实例研究中性交后治疗延迟的分布情况,人群平均最大有效率仅为 49% 至 67%。结论:在个人层面上,在性生活前几小时服用 LNG-EC 是《部分实践建议》中关于提前供应避孕药的合理延伸,根据我们的建模,应该提倡那些可以合理预计会发生无保护性行为的人服用。然而,在缺乏更多临床数据的情况下,除非人们无法获得有效的现代避孕药具,否则不应常规依靠在性爱前服用 LNG-EC 来避孕。
{"title":"Maximizing the effectiveness of 1.5 mg levonorgestrel for emergency contraception: The case for precoital use","authors":"Douglas J. Taylor ,&nbsp;Nathalie Kapp ,&nbsp;Markus J. Steiner","doi":"10.1016/j.conx.2024.100107","DOIUrl":"10.1016/j.conx.2024.100107","url":null,"abstract":"<div><h3>Objectives</h3><p>U.S. and World Health Organization Selected Practice Recommendations for Contraceptive Use state people may have an advanced supply of emergency contraception (EC) to minimize treatment delays. We sought to characterize the potential improvement in effectiveness of 1.5 mg levonorgestrel (LNG-EC) if it were taken up to a few hours before unprotected sex.</p></div><div><h3>Study design</h3><p>We expanded on an existing mathematical model for the maximum attainable effectiveness of LNG-EC, assuming it exclusively works to disrupt ovulation, and compared results with point estimates from nine studies when it was taken up to 72 hours after sex. We then modelled how effectiveness might have improved if subjects had taken LNG-EC up to 3 hours before sex.</p></div><div><h3>Results</h3><p>Taking LNG-EC immediately after sex could potentially reduce the risk of unintended pregnancy by 91%. However, population-average maximum attainable effectiveness levels ranged from just 49% to 67% when accounting for the distributions of postcoital treatment delays in the example studies. If half the subjects had taken it 3 hours before sex, then maximum effectiveness levels would have ranged from 70% to 81%.</p></div><div><h3>Conclusions</h3><p>At the individual level, taking LNG-EC a few hours before sex is a logical extension of Selected Practice Recommendations regarding an advanced supply of EC and, based on our modeling, should be advocated for people who can reasonably anticipate an unprotected sex act. In the absence of more clinical data, however, people should not routinely rely on precoital use of LNG-EC to prevent pregnancy unless modern, effective contraceptives are inaccessible to them.</p></div><div><h3>Implications</h3><p>Based on mathematical modeling, individuals who anticipate needing to take LNG-EC for an impending unprotected act of sex could further reduce their chance of an undesired pregnancy by taking it a few hours in advance.</p></div>","PeriodicalId":10655,"journal":{"name":"Contraception: X","volume":"6 ","pages":"Article 100107"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2590151624000042/pdfft?md5=5c64cf4a851ab4b573a91776200b11f3&pid=1-s2.0-S2590151624000042-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141136044","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Dilation and evacuation versus medication abortion at 15–24 weeks of gestation in low-middle income country: A retrospective cohort study 在中低收入国家,妊娠 15-24 周时进行扩宫和排空手术与药物流产的比较:回顾性队列研究
Q2 Medicine Pub Date : 2024-01-01 DOI: 10.1016/j.conx.2024.100110
Abraham Fessehaye Sium, Amani Nureddin Abdu, Zerihun Beyene

Objective

To compare the effectiveness and safety of dilation and evacuation (D&E) to that of medication abortion at 15–24 weeks in a low-middle income country.

Study design

We conducted a retrospective cohort on effectiveness and safety of D&E vs medication abortion at 15–24 weeks in an Ethiopian setting over a year (January 1–December 31, 2023). We looked at success (need for additional procedure) of both abortion procedures and their complication rates. Hemorrhage, infection, uterine perforation/rupture, and cervical tear were the complications we compared between the groups (D&E group vs medication abortion group). P-value less than 0.05 and Adjusted odds ratio (AOR) with 95% CI were used to present results significance.

Results

A total of 225 abortion cases (162 medication abortion cases and 63 D&E cases) at gestational age of 15–24 weeks were included in the final analysis. The mean gestational age was 18 ± 2.8 weeks in the D&E group compared to 21 ± 3 weeks in the medication abortion group (p-value < 0.001). The overall procedure effectiveness between the abortion procedures was similar (95.2% vs 96.9% in the D&E group and medication abortion groups, p-value = 0.542). D&E (AOR = 2.92 [95% CI = 0.62–13.69]) was not associated with increased overall complications compared to medication abortion, after controlling for parity, gestational age, and history of prior uterine scar.

Conclusion

We found both abortion methods (D&E and medication abortion) are effective with comparable complication rates.

Implications

D&E and medication abortion are safe and effective methods of abortion for gestations up to 24 weeks even in a low-middle income country (LMIC) setting; as such, greater resources are needed to ensure to increase availability of D&E in order for women to have a choice in their treatment options.

研究设计我们在埃塞俄比亚进行了一项回顾性队列研究,对 15-24 周扩张排空术(D&E)与药物流产的有效性和安全性进行了为期一年(2023 年 1 月 1 日至 12 月 31 日)的比较。我们调查了两种人工流产手术的成功率(是否需要额外手术)及其并发症发生率。出血、感染、子宫穿孔/破裂和宫颈撕裂是我们比较的两组(D&E 组和药物流产组)并发症。P 值小于 0.05 和调整后的几率比(AOR)(95% CI)用于表示结果的显著性。结果 最终分析共纳入 225 例孕龄在 15-24 周的人工流产病例(药物流产 162 例,D&E 63 例)。D&E组的平均孕周为18 ± 2.8周,而药物流产组的平均孕周为21 ± 3周(P值为0.001)。两种人工流产术的总有效率相似(D&E 组和药物流产组的有效率分别为 95.2% 和 96.9%,P 值 = 0.542)。与药物流产相比,D&E(AOR = 2.92 [95% CI = 0.62-13.69])与总体并发症的增加无关,在控制了奇偶数、妊娠年龄和既往子宫疤痕史之后,D&E(AOR = 2.92 [95% CI = 0.62-13.69])与并发症的增加无关。意义即使在中低收入国家(LMIC),D&E 和药物流产对妊娠 24 周以内的妇女来说都是安全有效的流产方法;因此,需要更多资源来确保增加 D&E 的可用性,以便妇女在治疗方案中有所选择。
{"title":"Dilation and evacuation versus medication abortion at 15–24 weeks of gestation in low-middle income country: A retrospective cohort study","authors":"Abraham Fessehaye Sium,&nbsp;Amani Nureddin Abdu,&nbsp;Zerihun Beyene","doi":"10.1016/j.conx.2024.100110","DOIUrl":"10.1016/j.conx.2024.100110","url":null,"abstract":"<div><h3>Objective</h3><p>To compare the effectiveness and safety of dilation and evacuation (D&amp;E) to that of medication abortion at 15–24 weeks in a low-middle income country.</p></div><div><h3>Study design</h3><p>We conducted a retrospective cohort on effectiveness and safety of D&amp;E vs medication abortion at 15–24 weeks in an Ethiopian setting over a year (January 1–December 31, 2023). We looked at success (need for additional procedure) of both abortion procedures and their complication rates. Hemorrhage, infection, uterine perforation/rupture, and cervical tear were the complications we compared between the groups (D&amp;E group vs medication abortion group). <em>P</em>-value less than 0.05 and Adjusted odds ratio (AOR) with 95% CI were used to present results significance.</p></div><div><h3>Results</h3><p>A total of 225 abortion cases (162 medication abortion cases and 63 D&amp;E cases) at gestational age of 15–24 weeks were included in the final analysis. The mean gestational age was 18 ± 2.8 weeks in the D&amp;E group compared to 21 ± 3 weeks in the medication abortion group (<em>p</em>-value<!--> <!-->&lt;<!--> <!-->0.001). The overall procedure effectiveness between the abortion procedures was similar (95.2% vs 96.9% in the D&amp;E group and medication abortion groups, <em>p</em>-value<!--> <!-->=<!--> <!-->0.542). D&amp;E (AOR<!--> <!-->=<!--> <!-->2.92 [95% CI<!--> <!-->=<!--> <!-->0.62–13.69]) was not associated with increased overall complications compared to medication abortion, after controlling for parity, gestational age, and history of prior uterine scar.</p></div><div><h3>Conclusion</h3><p>We found both abortion methods (D&amp;E and medication abortion) are effective with comparable complication rates.</p></div><div><h3>Implications</h3><p>D&amp;E and medication abortion are safe and effective methods of abortion for gestations up to 24 weeks even in a low-middle income country (LMIC) setting; as such, greater resources are needed to ensure to increase availability of D&amp;E in order for women to have a choice in their treatment options.</p></div>","PeriodicalId":10655,"journal":{"name":"Contraception: X","volume":"6 ","pages":"Article 100110"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2590151624000078/pdfft?md5=f4cf2c2381c0def0532e91cb2471a6ce&pid=1-s2.0-S2590151624000078-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142084003","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Experiences of delay-causing obstacles and mental health at the time of abortion seeking 寻求堕胎时遇到的导致延误的障碍和心理健康。
Q2 Medicine Pub Date : 2024-01-01 DOI: 10.1016/j.conx.2024.100105
Ortal Wasser , Lauren J. Ralph , Shelly Kaller , M. Antonia Biggs

Objectives

The delays and challenges people encounter when seeking abortion are well-documented, but their psychological implications are understudied. Aiming to fill this gap, we explored the associations between experiences of delay-causing obstacles to abortion care and adverse mental health symptoms among individuals seeking abortion care.

Study design

In 2019, we surveyed 784 people (of 1092 approached) ages 15–45 accessing abortion care in four clinics in abortion-supportive states: California, Illinois, and New Mexico. We conducted multivariable Poisson regressions to examine associations between experiencing delay-causing obstacles to abortion care and stress, anxiety, and depression at the abortion appointment. We also used Poisson regression to examine whether some individuals are more likely to experience delay-causing obstacles than others.

Results

Three in five participants (58%) experienced delay-causing obstacles when accessing abortion care. The most prevalent obstacles were cost-related (45%), followed by access-related (43%), and travel time-related (35%) delays. In adjusted analyses, experiencing any type of delay-causing obstacle to abortion care was significantly associated with more symptoms of stress, anxiety, and depression and higher risk of anxiety and depressive disorders. Participants were more likely to experience delay-causing obstacles if they traveled from another state or over 100 miles to reach the clinic, sought abortion beyond 13 weeks gestation, lacked money for unexpected expenses, and found it difficult to pay for the abortion.

Conclusion

Abortion is a time-sensitive healthcare, but most individuals are forced to delay care due to various obstacles that may have a negative impact on their psychological well-being.

Implications

Obstacles causing delays in accessing abortion care may contribute to elevated symptoms of stress, anxiety, and depression and higher risk of anxiety and depressive disorders for abortion patients. As restrictive policies increase, delays are likely to worsen, potentially leading to psychological harm for people seeking abortion.

目标人们在寻求人工流产时遇到的延误和挑战已被充分记录,但其心理影响却未得到充分研究。为了填补这一空白,我们探讨了在寻求人工流产护理的个人中,导致人工流产护理延迟的障碍经历与不良心理健康症状之间的关联。研究设计2019 年,我们调查了在支持人工流产的州的四家诊所接受人工流产护理的 784 名 15-45 岁的患者(共 1092 人):加利福尼亚州、伊利诺伊州和新墨西哥州。我们进行了多变量泊松回归,以研究在流产预约时遇到导致流产护理延迟的障碍与压力、焦虑和抑郁之间的关联。我们还使用泊松回归法研究了某些人是否比其他人更容易遇到导致延误的障碍。结果五分之三的参与者(58%)在获得堕胎护理时遇到了导致延误的障碍。最普遍的障碍是与费用相关的障碍(45%),其次是与就医相关的障碍(43%)和与旅行时间相关的障碍(35%)。在调整后的分析中,流产护理时遇到任何类型的延误障碍都与更多的压力、焦虑和抑郁症状以及更高的焦虑症和抑郁症风险密切相关。如果受试者从另一个州或超过 100 英里之外的地方前往诊所、妊娠超过 13 周才寻求堕胎、没有钱支付意外费用,以及发现难以支付堕胎费用,则更有可能遇到导致延误的障碍。结论人工流产是一项时效性很强的医疗服务,但大多数人却因为各种障碍而被迫推迟接受治疗,这可能会对他们的心理健康产生负面影响。影响造成人工流产治疗延误的障碍可能会导致人工流产患者的压力、焦虑和抑郁症状升高,以及患焦虑症和抑郁症的风险升高。随着限制性政策的增加,延误可能会加剧,从而可能导致寻求人工流产者的心理伤害。
{"title":"Experiences of delay-causing obstacles and mental health at the time of abortion seeking","authors":"Ortal Wasser ,&nbsp;Lauren J. Ralph ,&nbsp;Shelly Kaller ,&nbsp;M. Antonia Biggs","doi":"10.1016/j.conx.2024.100105","DOIUrl":"10.1016/j.conx.2024.100105","url":null,"abstract":"<div><h3>Objectives</h3><p>The delays and challenges people encounter when seeking abortion are well-documented, but their psychological implications are understudied. Aiming to fill this gap, we explored the associations between experiences of delay-causing obstacles to abortion care and adverse mental health symptoms among individuals seeking abortion care.</p></div><div><h3>Study design</h3><p>In 2019, we surveyed 784 people (of 1092 approached) ages 15–45 accessing abortion care in four clinics in abortion-supportive states: California, Illinois, and New Mexico. We conducted multivariable Poisson regressions to examine associations between experiencing delay-causing obstacles to abortion care and stress, anxiety, and depression at the abortion appointment. We also used Poisson regression to examine whether some individuals are more likely to experience delay-causing obstacles than others.</p></div><div><h3>Results</h3><p>Three in five participants (58%) experienced delay-causing obstacles when accessing abortion care. The most prevalent obstacles were cost-related (45%), followed by access-related (43%), and travel time-related (35%) delays. In adjusted analyses, experiencing any type of delay-causing obstacle to abortion care was significantly associated with more symptoms of stress, anxiety, and depression and higher risk of anxiety and depressive disorders. Participants were more likely to experience delay-causing obstacles if they traveled from another state or over 100 miles to reach the clinic, sought abortion beyond 13 weeks gestation, lacked money for unexpected expenses, and found it difficult to pay for the abortion.</p></div><div><h3>Conclusion</h3><p>Abortion is a time-sensitive healthcare, but most individuals are forced to delay care due to various obstacles that may have a negative impact on their psychological well-being.</p></div><div><h3>Implications</h3><p>Obstacles causing delays in accessing abortion care may contribute to elevated symptoms of stress, anxiety, and depression and higher risk of anxiety and depressive disorders for abortion patients. As restrictive policies increase, delays are likely to worsen, potentially leading to psychological harm for people seeking abortion.</p></div>","PeriodicalId":10655,"journal":{"name":"Contraception: X","volume":"6 ","pages":"Article 100105"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2590151624000029/pdfft?md5=9afc1159cd88ea22b96691c7ff671cb7&pid=1-s2.0-S2590151624000029-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140088463","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation of the London Measure of Unplanned Pregnancy (LMUP) among a nationally representative sample of pregnant and postpartum women Ethiopia 在埃塞俄比亚孕妇和产后妇女的全国代表性样本中评估伦敦计划外怀孕措施(LMUP)
Q2 Medicine Pub Date : 2023-01-01 DOI: 10.1016/j.conx.2023.100094
Celia Karp , Caroline Moreau , Solomon Shiferaw , Assefa Seme , Mahari Yihdego , Linnea A. Zimmerman

Objectives

Rigorous measurement of pregnancy preferences is needed to address reproductive health needs. The London Measure of Unplanned Pregnancy (LMUP), developed in the UK, has been adapted for low-income countries. Psychometric properties of LMUP items remain uncertain in contexts with limited access to and use of health services.

Study design

This cross-sectional study examines the six-item LMUP’s psychometric properties among a nationally representative sample of 2855 pregnant and postpartum women in Ethiopia. Principal components analysis (PCA) and confirmatory factor analysis (CFA) estimated psychometric properties. Hypothesis testing examined associations between the LMUP and other measurement approaches of pregnancy preferences using descriptive statistics and linear regression.

Results

The six-item LMUP had acceptable reliability (α = 0.77); two behavioral items (contraception, preconception care) were poorly correlated with the total scale. A four-item measure demonstrated higher reliability (α = 0.90). Construct validity via PCA and CFA indicated the four-item LMUP’s unidimensionality and good model fit; all hypotheses related to the four-item LMUP and other measurement approaches were met.

Conclusions

Measurement of women’s pregnancy planning in Ethiopia may be improved through use of a four-item version of the LMUP scale. This measurement approach can inform family planning services to better align with women’s reproductive goals.

Implications

Improved pregnancy preference measures are needed to understand reproductive health needs. A four-item version of the LMUP is highly reliable in Ethiopia, offering a robust and concise metric for assessing women’s orientations toward a current or recent pregnancy and tailoring care to support them in achieving their reproductive goals.

目的需要严格测量妊娠偏好,以满足生殖健康需求。英国制定的伦敦计划外妊娠测量(LMUP)已针对低收入国家进行了调整。在获得和使用卫生服务有限的情况下,LMUP项目的心理测量特性仍然不确定。研究设计这项横断面研究在埃塞俄比亚2855名孕妇和产后妇女的全国代表性样本中检验了六项LMUP的心理测量特性。主成分分析(PCA)和验证性因素分析(CFA)估计了心理测量特性。假设检验使用描述性统计和线性回归检验了LMUP和其他妊娠偏好测量方法之间的相关性。结果六项LMUP具有可接受的信度(α=0.77);两个行为项目(避孕、孕前护理)与总量表的相关性很差。四项测量显示出较高的信度(α=0.90)。通过PCA和CFA的结构有效性表明四项LMUP的单维度性和良好的模型拟合性;符合与四项LMUP和其他测量方法相关的所有假设。结论通过使用LMUP量表的四项版本,可以改善埃塞俄比亚妇女计划生育的测量。这种衡量方法可以为计划生育服务提供信息,以便更好地与妇女的生殖目标保持一致。含义需要改进妊娠偏好措施,以了解生殖健康需求。LMUP的四项版本在埃塞俄比亚非常可靠,为评估女性当前或近期怀孕的倾向提供了一个有力而简洁的指标,并为她们实现生育目标提供了量身定制的护理。
{"title":"Evaluation of the London Measure of Unplanned Pregnancy (LMUP) among a nationally representative sample of pregnant and postpartum women Ethiopia","authors":"Celia Karp ,&nbsp;Caroline Moreau ,&nbsp;Solomon Shiferaw ,&nbsp;Assefa Seme ,&nbsp;Mahari Yihdego ,&nbsp;Linnea A. Zimmerman","doi":"10.1016/j.conx.2023.100094","DOIUrl":"10.1016/j.conx.2023.100094","url":null,"abstract":"<div><h3>Objectives</h3><p>Rigorous measurement of pregnancy preferences is needed to address reproductive health needs. The London Measure of Unplanned Pregnancy (LMUP), developed in the UK, has been adapted for low-income countries. Psychometric properties of LMUP items remain uncertain in contexts with limited access to and use of health services.</p></div><div><h3>Study design</h3><p>This cross-sectional study examines the six-item LMUP’s psychometric properties among a nationally representative sample of 2855 pregnant and postpartum women in Ethiopia. Principal components analysis (PCA) and confirmatory factor analysis (CFA) estimated psychometric properties. Hypothesis testing examined associations between the LMUP and other measurement approaches of pregnancy preferences using descriptive statistics and linear regression.</p></div><div><h3>Results</h3><p>The six-item LMUP had acceptable reliability (α = 0.77); two behavioral items (contraception, preconception care) were poorly correlated with the total scale. A four-item measure demonstrated higher reliability (α = 0.90). Construct validity via PCA and CFA indicated the four-item LMUP’s unidimensionality and good model fit; all hypotheses related to the four-item LMUP and other measurement approaches were met.</p></div><div><h3>Conclusions</h3><p>Measurement of women’s pregnancy planning in Ethiopia may be improved through use of a four-item version of the LMUP scale. This measurement approach can inform family planning services to better align with women’s reproductive goals.</p></div><div><h3>Implications</h3><p>Improved pregnancy preference measures are needed to understand reproductive health needs. A four-item version of the LMUP is highly reliable in Ethiopia, offering a robust and concise metric for assessing women’s orientations toward a current or recent pregnancy and tailoring care to support them in achieving their reproductive goals.</p></div>","PeriodicalId":10655,"journal":{"name":"Contraception: X","volume":"5 ","pages":"Article 100094"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10176025/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9829713","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Clinical outcomes of intrauterine device insertions by newly trained providers: The ECHO trial experience 新培训提供者宫内节育器插入的临床结果:ECHO试验经验
Q2 Medicine Pub Date : 2023-01-01 DOI: 10.1016/j.conx.2023.100092
Irina Yacobson , Valentine Wanga , Khatija Ahmed , Tsungai Chipato , Peter Gichangi , James Kiarie , Cheryl Louw , Susan Morrison , Margaret Moss , Nelly R. Mugo , Thesla Palanee-Phillips , Melanie Pleaner , Caitlin W. Scoville , Katherine K. Thomas , Kavita Nanda , for the Evidence for Contraceptive Options and HIV Outcomes (ECHO) Trial Consortium

Objectives

To assess the rates of failed insertion, expulsion, and perforation when intrauterine device (IUD) insertions were done by newly trained clinicians, and to examine factors that may affect these outcomes.

Study design

We evaluated skill-based outcomes following IUD insertion at 12 African sites in a secondary analysis of the Evidence for Contraceptive Options and HIV Outcomes (ECHO) randomized trial. Before trial initiation, we provided competency-based IUD training to clinicians and offered ongoing clinical support. We used Cox proportional hazards regression to examine factors associated with expulsion.

Results

Among 2582 IUD acceptors who underwent first attempted IUD insertion, 141 experienced insertion failure (5.46%) and seven had uterine perforation (0.27%). Perforation was more common among breastfeeding women within three months postpartum (0.65%) compared with non-breastfeeding women (0.22%). We recorded 493 expulsions (15.5 per 100 person-years, 95% confidence interval [CI] 14.1─16.9): 383 partial and 110 complete. The risk of IUD expulsion was lower among women older than 24 years (aHR 0.63, 95% CI 0.50─0.78) and may be higher among nulliparous women. (aHR 1.65, 95% CI 0.97─2.82). Breastfeeding (aHR 0.94, 95% CI 0.72─1.22) had no significant effect on expulsion. IUD expulsion rate was highest during the first three months of the trial.

Conclusions

IUD insertion failure and uterine perforation rates in our study were comparable to those reported in the literature. These results suggest that training, ongoing support, and opportunities to apply new skills were effective in ensuring good clinical outcomes for women receiving IUD insertion by newly trained providers.

Implications

Data from this study support recommendations to program managers, policymakers, and clinicians that IUDs can be inserted safely in resource-constrained settings when providers receive appropriate training and support.

目的评估由新培训的临床医生进行宫内节育器(IUD)插入时,插入、排出和穿孔失败的发生率,并检查可能影响这些结果的因素。研究设计我们在对避孕选择和HIV结果证据(ECHO)随机试验的二次分析中,评估了在12个非洲地区放置宫内节育器后基于技能的结果。在试验开始之前,我们为临床医生提供了基于能力的宫内节育器培训,并提供持续的临床支持。我们使用Cox比例风险回归来检验与驱逐相关的因素。结果2582名首次尝试宫内节育器插入的宫内节育器受体中,141人(5.46%)插入失败,7人出现子宫穿孔(0.27%)。与非母乳喂养妇女(0.22%)相比,产后3个月内母乳喂养妇女穿孔更常见(0.65%)─16.9):383部分和110完整。24岁以上女性宫内节育器排出的风险较低(aHR 0.63,95%CI 0.50─0.78),在未产妇中可能更高。(aHR 1.65,95%CI 0.97─2.82)。母乳喂养(aHR 0.94,95%CI 0.72─1.22)对驱逐没有显著影响。宫内节育器排出率在试验的前三个月最高。结论本研究中sIUD插入失败率和子宫穿孔率与文献报道相当。这些结果表明,培训、持续的支持和应用新技能的机会有效地确保了接受新培训的提供者插入宫内节育器的妇女获得良好的临床结果。含义本研究的数据支持向项目经理、决策者和临床医生提出的建议,即当提供者接受适当的培训和支持时,宫内节育器可以安全地插入资源受限的环境中。
{"title":"Clinical outcomes of intrauterine device insertions by newly trained providers: The ECHO trial experience","authors":"Irina Yacobson ,&nbsp;Valentine Wanga ,&nbsp;Khatija Ahmed ,&nbsp;Tsungai Chipato ,&nbsp;Peter Gichangi ,&nbsp;James Kiarie ,&nbsp;Cheryl Louw ,&nbsp;Susan Morrison ,&nbsp;Margaret Moss ,&nbsp;Nelly R. Mugo ,&nbsp;Thesla Palanee-Phillips ,&nbsp;Melanie Pleaner ,&nbsp;Caitlin W. Scoville ,&nbsp;Katherine K. Thomas ,&nbsp;Kavita Nanda ,&nbsp;for the Evidence for Contraceptive Options and HIV Outcomes (ECHO) Trial Consortium","doi":"10.1016/j.conx.2023.100092","DOIUrl":"10.1016/j.conx.2023.100092","url":null,"abstract":"<div><h3>Objectives</h3><p>To assess the rates of failed insertion, expulsion, and perforation when intrauterine device (IUD) insertions were done by newly trained clinicians, and to examine factors that may affect these outcomes.</p></div><div><h3>Study design</h3><p>We evaluated skill-based outcomes following IUD insertion at 12 African sites in a secondary analysis of the Evidence for Contraceptive Options and HIV Outcomes (ECHO) randomized trial. Before trial initiation, we provided competency-based IUD training to clinicians and offered ongoing clinical support. We used Cox proportional hazards regression to examine factors associated with expulsion.</p></div><div><h3>Results</h3><p>Among 2582 IUD acceptors who underwent first attempted IUD insertion, 141 experienced insertion failure (5.46%) and seven had uterine perforation (0.27%). Perforation was more common among breastfeeding women within three months postpartum (0.65%) compared with non-breastfeeding women (0.22%). We recorded 493 expulsions (15.5 per 100 person-years, 95% confidence interval [CI] 14.1─16.9): 383 partial and 110 complete. The risk of IUD expulsion was lower among women older than 24 years (aHR 0.63, 95% CI 0.50─0.78) and may be higher among nulliparous women. (aHR 1.65, 95% CI 0.97─2.82). Breastfeeding (aHR 0.94, 95% CI 0.72─1.22) had no significant effect on expulsion. IUD expulsion rate was highest during the first three months of the trial.</p></div><div><h3>Conclusions</h3><p>IUD insertion failure and uterine perforation rates in our study were comparable to those reported in the literature. These results suggest that training, ongoing support, and opportunities to apply new skills were effective in ensuring good clinical outcomes for women receiving IUD insertion by newly trained providers.</p></div><div><h3>Implications</h3><p>Data from this study support recommendations to program managers, policymakers, and clinicians that IUDs can be inserted safely in resource-constrained settings when providers receive appropriate training and support.</p></div>","PeriodicalId":10655,"journal":{"name":"Contraception: X","volume":"5 ","pages":"Article 100092"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10176026/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10139740","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
“If I use family planning, I may have trouble getting pregnant next time I want to”: A multicountry survey-based exploration of perceived contraceptive-induced fertility impairment and its relationship to contraceptive behaviors “如果我使用计划生育,下次我想要怀孕的时候可能会有困难”:一项基于多国调查的关于避孕药引起的生育障碍及其与避孕行为的关系的探索
Q2 Medicine Pub Date : 2023-01-01 DOI: 10.1016/j.conx.2023.100093
Suzanne O. Bell , Celia Karp , Caroline Moreau , PMA Principal Investigators Group , Alison Gemmill

Objectives

We aim to assess women’s perceptions regarding contraceptive effects on fertility across a diversity of settings in sub-Saharan Africa and how they vary by women’s characteristics. We also aim to examine how such beliefs relate to women’s contraceptive practices and intentions.

Study design

This study uses cross-sectional survey data among women aged 15 to 49 in nine sub-Saharan African geographies from the Performance Monitoring for Action project. Our main measure of interest assessed women’s perceptions of contraceptive-induced fertility impairment. We examined factors related to this belief and explored the association between perceptions of contraceptive-induced fertility impairment and use of medicalized contraception (intrauterine device, implant, injectable, pills, emergency contraception) and intention to use contraception (among nonusers).

Results

Between 20% and 40% of women across study sites agreed or strongly agreed that contraception would lead to later difficulties becoming pregnant. Women at risk of an unintended pregnancy who believed contraception could cause fertility impairment had reduced odds of using medicalized contraception in five sites; aORs ranged from 0.07 to 0.62. Likewise, contraceptive nonusers who wanted a/another child and perceived contraception could cause fertility impairment were less likely to intend to use contraception in seven sites, with aORs between 0.34 and 0.66.

Conclusions

Our multicountry study findings indicate women’s perception of contraceptive-induced fertility impairment is common across diverse sub-Saharan African settings, likely acting as a deterrent to using medicalized contraceptive methods.

Implications

Findings from this study can help improve reproductive health programs by addressing concerns about contraception to help women achieve their reproductive goals.

目的我们旨在评估撒哈拉以南非洲不同环境中女性对避孕措施对生育能力的影响的看法,以及这些看法如何因女性特征而异。我们还旨在研究这种信念与妇女的避孕做法和意图之间的关系。研究设计本研究使用了行动绩效监测项目中撒哈拉以南非洲九个地区15至49岁女性的横断面调查数据。我们感兴趣的主要指标评估了女性对避孕引起的生育障碍的看法。我们研究了与这一观点相关的因素,并探讨了避孕引起的生育障碍的认知与药物避孕(宫内节育器、植入物、注射物、药丸、紧急避孕)的使用和避孕意图(非使用者)之间的关系避孕会导致以后怀孕困难。有意外怀孕风险的女性认为避孕会导致生育障碍,在五个地点使用药物避孕的几率降低;aOR在0.07-0.62之间。同样,在七个地区,想要一个/另一个孩子并且认为避孕会导致生育障碍的非避孕者不太可能打算避孕,aOR在0.34至0.66之间。结论我们的多国研究结果表明,在撒哈拉以南非洲的不同环境中,女性对避孕导致的生育障碍的看法很普遍,可能对使用药物避孕方法起到威慑作用。这项研究的结果可以通过解决人们对避孕的担忧来帮助女性实现生育目标,从而有助于改善生殖健康计划。
{"title":"“If I use family planning, I may have trouble getting pregnant next time I want to”: A multicountry survey-based exploration of perceived contraceptive-induced fertility impairment and its relationship to contraceptive behaviors","authors":"Suzanne O. Bell ,&nbsp;Celia Karp ,&nbsp;Caroline Moreau ,&nbsp;PMA Principal Investigators Group ,&nbsp;Alison Gemmill","doi":"10.1016/j.conx.2023.100093","DOIUrl":"10.1016/j.conx.2023.100093","url":null,"abstract":"<div><h3>Objectives</h3><p>We aim to assess women’s perceptions regarding contraceptive effects on fertility across a diversity of settings in sub-Saharan Africa and how they vary by women’s characteristics. We also aim to examine how such beliefs relate to women’s contraceptive practices and intentions.</p></div><div><h3>Study design</h3><p>This study uses cross-sectional survey data among women aged 15 to 49 in nine sub-Saharan African geographies from the Performance Monitoring for Action project. Our main measure of interest assessed women’s perceptions of contraceptive-induced fertility impairment. We examined factors related to this belief and explored the association between perceptions of contraceptive-induced fertility impairment and use of medicalized contraception (intrauterine device, implant, injectable, pills, emergency contraception) and intention to use contraception (among nonusers).</p></div><div><h3>Results</h3><p>Between 20% and 40% of women across study sites agreed or strongly agreed that contraception would lead to later difficulties becoming pregnant. Women at risk of an unintended pregnancy who believed contraception could cause fertility impairment had reduced odds of using medicalized contraception in five sites; aORs ranged from 0.07 to 0.62. Likewise, contraceptive nonusers who wanted a/another child and perceived contraception could cause fertility impairment were less likely to intend to use contraception in seven sites, with aORs between 0.34 and 0.66.</p></div><div><h3>Conclusions</h3><p>Our multicountry study findings indicate women’s perception of contraceptive-induced fertility impairment is common across diverse sub-Saharan African settings, likely acting as a deterrent to using medicalized contraceptive methods.</p></div><div><h3><strong>Implications</strong></h3><p>Findings from this study can help improve reproductive health programs by addressing concerns about contraception to help women achieve their reproductive goals.</p></div>","PeriodicalId":10655,"journal":{"name":"Contraception: X","volume":"5 ","pages":"Article 100093"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10127128/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10101606","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Knowledge, attitude, and intended practice of abortion among medical students in Thailand after the amendment of the Thai abortion law 泰国堕胎法修订后,泰国医学生对堕胎的知识、态度和预期做法
Q2 Medicine Pub Date : 2023-01-01 DOI: 10.1016/j.conx.2023.100091
Rada Poolkumlung , Ratthapong Rongkapich , Natchanika Sinthuchai , Somsook Santibenchakul , Vorachart Meevasana , Unnop Jaisamrarn

Objectives

Following the amendment of the Thai abortion law in February 2021, the authors conducted an anonymous survey to assess knowledge, attitude, and intended practice toward abortion among fifth-year medical students at Chulalongkorn University.

Study design

The authors developed a self-administrated questionnaire consisting of three parts: knowledge of the recently amended Thai abortion law, attitude toward abortion, and intended practices. Pilot testing showed a high Cronbach's alpha and test-retest reliability coefficient.

Results

Of the 292 surveyed medical students, 70% completed the questionnaire. The mean ± standard deviation of the knowledge part was 6.9 ± 1.8, of which the maximum score was 10. Nearly half of the participants (45.6%) answered at least 80% of the knowledge statements correctly. Sixty-four percent of participants answered correctly on the gestational limit for first-trimester abortion. Around one-third of participants answered correctly on the gestational limit for second-trimester abortion. Most participants (86.8%) agreed that abortion is a woman’s right. The most acceptable conditions for abortion were pregnancy as a result of rape (93%) and serious anomalies that cause a nonviable neonate (95.6%).

Conclusions

Participants exhibited a lack of understanding regarding the legal gestational limit, which is a key aspect of the amendment. The findings of this study urge medical schools to emphasize the revised Thai abortion law in the Obstetrics and Gynecology curriculum.

Implications

Our results show that encouraging medical students to have up-to-date knowledge regarding the amendment of Thai abortion law may support their future decision to provide safe abortion services.

目的在2021年2月泰国堕胎法修订后,作者进行了一项匿名调查,评估朱拉隆功大学五年级医学生对堕胎的知识、态度和预期做法。研究设计作者编制了一份自我管理的问卷,由三部分组成:对最近修订的泰国堕胎法的了解、对堕胎的态度和预期做法。初步测试显示出较高的Cronbachα和重新测试的可靠性系数。结果在292名医学生中,70%的学生完成了问卷调查。知识部分的平均值±标准差为6.9±1.8,其中最高分为10分。近一半的参与者(45.6%)至少正确回答了80%的知识陈述。64%的参与者对妊娠早期流产的妊娠限制回答正确。大约三分之一的参与者对妊娠中期堕胎的妊娠限制回答正确。大多数参与者(86.8%)同意堕胎是妇女的权利。最可接受的堕胎条件是强奸导致的妊娠(93%)和导致新生儿无法存活的严重异常(95.6%)。结论参与者对法律妊娠期限制缺乏了解,这是修正案的一个关键方面。这项研究的结果促使医学院在妇产科课程中强调修改后的泰国堕胎法。含义我们的研究结果表明,鼓励医学生掌握有关泰国堕胎法修正案的最新知识,可能会支持他们未来提供安全堕胎服务的决定。
{"title":"Knowledge, attitude, and intended practice of abortion among medical students in Thailand after the amendment of the Thai abortion law","authors":"Rada Poolkumlung ,&nbsp;Ratthapong Rongkapich ,&nbsp;Natchanika Sinthuchai ,&nbsp;Somsook Santibenchakul ,&nbsp;Vorachart Meevasana ,&nbsp;Unnop Jaisamrarn","doi":"10.1016/j.conx.2023.100091","DOIUrl":"10.1016/j.conx.2023.100091","url":null,"abstract":"<div><h3>Objectives</h3><p>Following the amendment of the Thai abortion law in February 2021, the authors conducted an anonymous survey to assess knowledge, attitude, and intended practice toward abortion among fifth-year medical students at Chulalongkorn University.</p></div><div><h3>Study design</h3><p>The authors developed a self-administrated questionnaire consisting of three parts: knowledge of the recently amended Thai abortion law, attitude toward abortion, and intended practices. Pilot testing showed a high Cronbach's alpha and test-retest reliability coefficient.</p></div><div><h3>Results</h3><p>Of the 292 surveyed medical students, 70% completed the questionnaire. The mean ± standard deviation of the knowledge part was 6.9 ± 1.8, of which the maximum score was 10. Nearly half of the participants (45.6%) answered at least 80% of the knowledge statements correctly. Sixty-four percent of participants answered correctly on the gestational limit for first-trimester abortion. Around one-third of participants answered correctly on the gestational limit for second-trimester abortion. Most participants (86.8%) agreed that abortion is a woman’s right. The most acceptable conditions for abortion were pregnancy as a result of rape (93%) and serious anomalies that cause a nonviable neonate (95.6%).</p></div><div><h3>Conclusions</h3><p>Participants exhibited a lack of understanding regarding the legal gestational limit, which is a key aspect of the amendment. The findings of this study urge medical schools to emphasize the revised Thai abortion law in the Obstetrics and Gynecology curriculum.</p></div><div><h3>Implications</h3><p>Our results show that encouraging medical students to have up-to-date knowledge regarding the amendment of Thai abortion law may support their future decision to provide safe abortion services.</p></div>","PeriodicalId":10655,"journal":{"name":"Contraception: X","volume":"5 ","pages":"Article 100091"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/21/f1/main.PMC10140783.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9386584","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Contraception: X
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1